GetTopicDetailResponse(id=6df412591ef3, topicName=心腎綜合征（CRS）, introduction=, content=超濾治療 心腎綜合征（CRS）, image=null, comments=0, allHits=140, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Apr 10 16:06:59 CST 2025, time=2025-04-10, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503372, tagList=[TagDto(tagId=503372, tagName=心腎綜合征（CRS）)], ipAttribution=四川省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2259918, encodeId=88872259918c2, content=<a href='/topic/show?id=38b0928e4b8' target=_blank style='color:#2F92EE;'>#超濾治療#</a> <a href='/topic/show?id=6df412591ef3' target=_blank style='color:#2F92EE;'>#心腎綜合征（CRS）#</a>, objectTitle=ESC Heart Fail：超濾治療心腎綜合征合并利尿劑抵抗患者的療效與安全性, objectType=article, longId=871270, objectId=d83c8e127078, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250122/1737522567541_8538692.png, objectUrl=/article/show_article.do?id=d83c8e127078, replyNumber=0, likeNumber=25, createdTime=2025-04-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=四川省, moduleDTOList=[ModuleDTO(moduleId=d83c8e127078, moduleTitle=ESC Heart Fail：超濾治療心腎綜合征合并利尿劑抵抗患者的療效與安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d83c8e127078)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-10發(fā)表于四川省
